NDC 50090-0481-01 - Naproxen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0481
- Requested NDC
- 50090-0481-01
- Package NDCs from labels
- 50090-0481-0, 50090-0481-7, 50090-0481-4, 50090-0481-5, 50090-0481-1, 50090-0481-9, 50090-0481-2, 50090-0481-6, 50090-0481-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-01-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naproxen - A-S Medication Solutions | A-S Medication Solutions | 2026-01-29 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0481-0 | Naproxen | 15 in 1 BOTTLE | TABLET | 15 | 31 | |
| 50090-0481-1 | Naproxen | 20 in 1 BOTTLE | TABLET | 20 | 31 | |
| 50090-0481-2 | Naproxen | 30 in 1 BOTTLE | TABLET | 30 | 31 | |
| 50090-0481-4 | Naproxen | 14 in 1 BOTTLE | TABLET | 14 | 31 | |
| 50090-0481-5 | Naproxen | 40 in 1 BOTTLE | TABLET | 40 | 31 | |
| 50090-0481-6 | Naproxen | 100 in 1 BOTTLE | TABLET | 100 | 31 | |
| 50090-0481-7 | Naproxen | 60 in 1 BOTTLE | TABLET | 60 | 31 | |
| 50090-0481-9 | Naproxen | 6 in 1 BOTTLE | TABLET | 6 | 31 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0481 | NAPROXEN TABLET [A-S MEDICATION SOLUTIONS] | 29 | Current NDC, Legacy NDC, 8 package rows | 20240905_000155a8-709c-44e5-a75f-cd890f3a7caf.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0481-0 | EA - Each | 50090-0481 | b73d0457-aa5d-44d1-9ffe-8e84bc4b53d5 | 1 | 2018-09-05 |
| 50090-0481-1 | EA - Each | 50090-0481 | 8d86527d-2599-4a30-82a6-c2dbd1b98722 | 1 | 2018-09-05 |
| 50090-0481-2 | EA - Each | 50090-0481 | d92301e9-5ae9-43b2-b86b-e58dad9eaea9 | 1 | 2018-09-05 |
| 50090-0481-4 | EA - Each | 50090-0481 | 1442acf3-7793-4a96-8ebf-f200f2e60bce | 1 | 2018-09-05 |
| 50090-0481-5 | EA - Each | 50090-0481 | bac00d6f-6aa6-473b-a517-2d181646cda1 | 1 | 2018-09-05 |
| 50090-0481-6 | EA - Each | 50090-0481 | 3c8620e3-6f7e-46f4-a0de-5ad10fba1c21 | 1 | 2018-09-05 |
| 50090-0481-7 | EA - Each | 50090-0481 | 33b2100d-a17f-4f6d-bad0-120a73bada72 | 1 | 2018-09-05 |
| 50090-0481-9 | EA - Each | 50090-0481 | 08fbf0d0-348d-48a8-b1a1-760f87e60643 | 1 | 2018-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aleve | NAPROXEN SODIUM | Bayer HealthCare LLC. | 31bad2d9-c0bb-7f20-e063-6294a90acb17 | 2025-04-01 | Warnings | 9TN87S3A3C |
| Aleve Back and Muscle Pain | NAPROXEN SODIUM | Bayer HealthCare LLC. | 31bae77b-42dd-94eb-e063-6294a90ad570 | 2025-04-01 | Warnings | 9TN87S3A3C |
| Aleve Headache Pain | NAPROXEN SODIUM | Bayer HealthCare LLC. | 31baf777-c805-21ea-e063-6394a90abbd8 | 2025-04-01 | Warnings | 9TN87S3A3C |
| Naproxen Sodium | NAPROXEN SODIUM | Bryant Ranch Prepack | 3d57ba5c-3a1d-435a-aa4f-9cc709e1b8cf | 2025-03-28 | Warnings | 9TN87S3A3C |
| Naproxen Oral Suspension | NAPROXEN ORAL | ANI Pharmaceuticals, Inc. | 252726a7-757a-4b97-b5b8-ffff4ac1d103 | 2025-03-25 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN | Bryant Ranch Prepack | 9d7bc470-fbba-40a6-a56c-f681a3cee9cf | 2025-03-24 | Boxed warning, Warnings, Adverse reactions | 198014 57Y76R9ATQ |
| Naproxen | NAPROXEN | Preferred Pharmaceuticals Inc. | 727913f6-9542-4a2d-9318-4b7ff521bffd | 2025-03-20 | Boxed warning, Warnings, Adverse reactions | ANDA078250 198012 57Y76R9ATQ |
| Naproxen | NAPROXEN | Amneal Pharmaceuticals of New York LLC | 2718e0b7-1ce6-457e-bee9-11b634dfd353 | 2025-03-18 | Boxed warning, Warnings, Adverse reactions | 198014 198013 198012 57Y76R9ATQ |
| rugby all day relief | NAPROXEN SODIUM | A-S Medication Solutions | 369f5123-283d-4aa6-8861-8d183f2ba94d | 2025-03-18 | Warnings | 9TN87S3A3C |
| RID Poison Ivy Rash Relief | CALAMINE AND ZINC OXIDE | Oystershell Consumer Health Inc. | 36c3af9a-2646-4427-e063-6394a90a2c5e | 2025-03-13 | Warnings | 1K09F3G675 |
| Care One Naproxen Sodium | NAPROXEN SODIUM | American Sales Company | 88812af7-89ca-449b-9513-20c284543d0e | 2025-03-13 | Warnings | 9TN87S3A3C |
| Naproxen | NAPROXEN | ANI Pharmaceuticals, Inc. | 052e6fe3-d619-42c3-b64e-67c7aaf7271c | 2025-03-12 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen and esomeprazole magnesium | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | ScieGen Pharmaceuticals, Inc | 167340c2-1234-4d00-b4e2-cccf3d270fda | 2025-03-06 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| CareOne Naproxen Sodium | NAPROXEN SODIUM | American Sales Company | 0ac4c343-a5b6-4f69-a75a-87074dc867e8 | 2025-03-04 | Warnings | 9TN87S3A3C |
| Naproxen Sodium | NAPROXEN SODIUM | Meijer Distribution Inc | 9551e84b-19bc-43e7-9c6e-0f24fdeb5abe | 2025-03-03 | Warnings | 9TN87S3A3C |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Naproxen | NAPROXEN SODIUM | Geri-Care Pharmaceutical Corp | 9a61d544-e46d-6703-e053-2a95a90a32fd | 2025-02-27 | Warnings | 9TN87S3A3C |
| Walgreens Soothing Eye Relief Lubricant Eye Drops | POLYVINYL ALCOHOL, POVIDONE | Walgreens Co. | 29b7387b-ad65-3a11-e063-6394a90a6a15 | 2025-02-14 | Warnings | FZ989GH94E |
| Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Cold | NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE | Aurohealth LLC | 638a9664-4129-46fd-9ba1-d660a7366c9f | 2025-02-12 | Warnings | 9TN87S3A3C |
| Calamine | FERRIC OXIDE RED | Preferred Pharmaceuticals Inc. | 326f3d80-c1bf-4cf0-a662-58e02ed7ee67 | 2025-02-12 | Warnings, Adverse reactions | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.